MedAvail Holdings amends Code of Conduct after retail pharmacy business sale

MedAvail Holdings, Inc.

Board approved amendments to Code of Conduct on August 17, 2023.
Changes primarily reflect sale of retail pharmacy services business.
Removed healthcare-specific references no longer applicable.
Added provisions on insider trading, antitrust, and international business laws.
Modified conflicts of interest disclosure requirements.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

MedAvail Holdings, Inc.: The Board of Directors approved amendments to the MedAvail Holdings, Inc. Code of Conduct and Ethics to reflect changes resulting from the sale of its retail pharmacy services business, remove healthcare-specific references, and add provisions on insider trading, antitrust, and international busines (effective 2023-08-17).

Change: code of ethics
Effective: 2023-08-17

Exact text from the filing

On August 17, 2023, the Board of Directors (the “ Board ”) of MedAvail Holdings, Inc., upon the recommendation of the Nominating and Corporate Governance Committee of the Board, approved amendments to the MedAvail Holdings, Inc. Code of Conduct and Ethics (the “ Code of Conduct ”).

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001402479-23-000090

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.